The estimated Net Worth of Mikael Dolsten is at least $53.2 Milhão dollars as of 7 November 2022. Mikael Dolsten owns over 79,108 units of Pfizer stock worth over $12,457,408 and over the last 12 years he sold PFE stock worth over $31,176,890. In addition, he makes $9,598,040 as Chief Scientific Officer, President - Worldwide Research, e Development and Medical at Pfizer.
Mikael has made over 26 trades of the Pfizer stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 79,108 units of PFE stock worth $2,627,177 on 7 November 2022.
The largest trade he's ever made was exercising 218,447 units of Pfizer stock on 23 February 2017 worth over $4,593,940. On average, Mikael trades about 27,548 units every 35 days since 2012. As of 7 November 2022 he still owns at least 420,007 units of Pfizer stock.
You can see the complete history of Mikael Dolsten stock trades at the bottom of the page.
Dr. Mikael G. Dolsten M.D., Ph.D. serves as Chief Scientific Officer, President - Worldwide Research, Development and Medical of the Company. He was Senior Vice President of Wyeth and President, Wyeth Research from June 2008 until October 2009. Director of Karyopharm Therapeutics Inc. Chairman of the Translational Advisory Board of Apple Tree Partners from 2016 to 2017.
As the Chief Scientific Officer, President - Worldwide Research, e Development and Medical of Pfizer, the total compensation of Mikael Dolsten at Pfizer is $9,598,040. There are 2 executives at Pfizer getting paid more, with Albert Bourla having the highest compensation of $17,929,000.
Mikael Dolsten is 61, he's been the Chief Scientific Officer, President - Worldwide Research, e Development and Medical of Pfizer since 2019. There are 9 older and 21 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read, eJames M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: